首页   按字顺浏览 期刊浏览 卷期浏览 Efficacy of Once- versus Thrice-Weekly Subcutaneous Recombinant Human Erythropoietin in...
Efficacy of Once- versus Thrice-Weekly Subcutaneous Recombinant Human Erythropoietin in Children Receiving Continuous Cycling Peritoneal Dialysis

 

作者: José Ramon C. Ongkingco,   Edward J. Ruley,   Mary.E. Turner,   Mary R. Fragale,  

 

期刊: American Journal of Nephrology  （Karger Available online 1994）
卷期: Volume 14, issue 1  

页码: 14-18

 

ISSN:0250-8095

 

年代: 1994

 

DOI:10.1159/000168680

 

出版商: S. Karger AG

 

关键词: End-stage renal disease;anemia;Recombinant human erythropoietin;weekly dosing;Single-dose pharmacokinetic studies;subcutaneous route

 

数据来源: Karger

 

摘要:

The subcutaneous administration of recombinant human erythropoietin is effective in the treatment of anemia of end-stage renal disease. Single-dose pharmacokinetic studies suggest the possibility of less frequent dosing via the subcutaneous route. In this study, dosing once-weekly was as effective as thrice-weekly subcutaneous dosing in maintaining the corrected hematocrit in a group of children receiving continuous cycling peritoneal dialysis. This regimen was preferred by and benificial to both patients and their parents.

 

点击下载:  PDF (944KB)



返 回